Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Amgen
(NQ:
AMGN
)
336.07
-6.33 (-1.85%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 20, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Amgen
< Previous
1
2
3
4
5
6
7
8
9
...
61
62
Next >
FDA Signs Off On Bayer's New Lung Cancer Drug — Early Results Look Promising
↗
Today 12:53 EST
FDA grants accelerated approval to Bayer's Hyrnuo and full approval to Amgen's Imdelltra, expanding treatment options for advanced lung cancer.
Via
Benzinga
Which S&P500 stocks are moving before the opening bell on Thursday?
↗
Today 8:35 EST
Before the US market kicks off on Thursday, let's examine the pre-market session and unveil the notable performers among the S&P500 top gainers and losers.
Via
Chartmill
Q3 Earnings Roundup: Myriad Genetics (NASDAQ:MYGN) And The Rest Of The Therapeutics Segment
November 18, 2025
Earnings results often indicate what direction a company will take in the months ahead. With Q3 behind us, let’s have a look at Myriad Genetics (NASDAQ:MYGN) and its peers.
Via
StockStory
Topics
Artificial Intelligence
Tech Stocks Drop, Pharma Gains As Sector Rotation Picks Up: What's Moving Markets Tuesday?
↗
November 18, 2025
Wall Street endured another wave of selling in tech stocks on Tuesday, with the Nasdaq 100 down more than 1% by midday in New York, extending its month-to-date slide to more than 5%.
Via
Benzinga
Amgen Stock Extends Rally After-Hours As CEO Hypes New Cholesterol Drug Data On Jim Cramer’s Show
↗
November 10, 2025
Via
Stocktwits
Check Out What Whales Are Doing With AMGN
↗
November 18, 2025
Via
Benzinga
1 Unpopular Stock That Deserves a Second Chance and 2 We Avoid
November 17, 2025
Wall Street has issued downbeat forecasts for the stocks in this article. These predictions are rare - financial institutions typically hesitate to say bad things about a company because it can...
Via
StockStory
This Sector Is Suddenly Crushing the Broader Market. Should You Invest $1,000?
↗
November 17, 2025
Healthcare stocks have far outperformed the broader market over the past month.
Via
The Motley Fool
Topics
ETFs
Government
World Trade
These 2 Dividend ETFs Are a Retiree's Best Friend
↗
November 16, 2025
Exchange-traded funds provide investors with exposure to a basket of stocks. Some also pay dividends.
Via
The Motley Fool
Topics
Artificial Intelligence
Bonds
ETFs
Healthcare Sector Navigates Mixed Market Close: A Beacon of Stability Amidst Uncertainty
November 14, 2025
As the broader market concluded with a mixed performance on November 14, 2025, the S&P 500 Healthcare sector once again underscored its often-defensive nature, demonstrating resilience amidst an...
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Intellectual Property
Fear Of An AI Bubble? This Sector Is Quietly Surging While Tech Sinks
↗
November 14, 2025
While AI stocks slide, healthcare is soaring. XLV leads November gains, outperforming tech as investors rotate.
Via
Benzinga
Topics
Artificial Intelligence
Why Amgen Stock Edged Past the Market on Thursday
↗
November 13, 2025
The pharmaceutical sector mainstay earned several positive mentions in the pundit sphere that day.
Via
The Motley Fool
Tech Sector Tremors: Is the AI Bubble Deflating, and What's Next for the Market?
November 13, 2025
As of mid-November 2025, a palpable unease has settled over the technology sector, long the darling of investors and the primary engine of market growth. After a period of unprecedented outperformance,...
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Stocks
2 Supercharged Dividend Stocks to Buy Now
↗
November 13, 2025
Innovative drugmakers often make for solid dividend stocks. These two companies are great examples.
Via
The Motley Fool
Topics
ETFs
Intellectual Property
A Closer Look at Amgen's Options Market Dynamics
↗
November 13, 2025
Via
Benzinga
Is the Schwab U.S. Dividend Equity ETF the "Ultimate Retirement Fund" for Investors?
↗
November 13, 2025
A $10,000 investment in this diversified fund at its 2011 inception would be worth $51,000 today.
Via
The Motley Fool
Topics
ETFs
Economy
Retirement
Nasdaq Stumbles: Tech Sector Faces Reality Check Amid Valuation Concerns and Sector Rotation
November 12, 2025
The Nasdaq Composite (NASDAQ: IXIC) experienced back-to-back losses on November 11 and 12, 2025, signaling a significant recalibration in the financial markets. This downturn, primarily driven by...
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Stocks
Dow Jones Soars to Unprecedented Heights as Market Cheers Government Shutdown Resolution
November 12, 2025
New York, NY – November 12, 2025 – The Dow Jones Industrial Average (DJIA) has shattered previous records, closing at an all-time high of 48,254.82 today, marking a significant milestone for the...
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Stocks
Unprecedented Market Anomaly: Gold and Silver Soar as Dow Breaches 48,000 Amidst Inflationary Fears and Geopolitical Tensions
November 12, 2025
The financial markets are currently exhibiting an extraordinary and complex phenomenon: both traditional safe-haven assets, gold and silver, are experiencing robust rallies, while the Dow Jones...
Via
MarketMinute
Topics
Artificial Intelligence
Bonds
Economy
Dow Soars Past 48,000 as Gold and Silver Shine in a Market of Paradox
November 12, 2025
New York, NY – November 12, 2025 – In a remarkable display of market resilience and underlying tension, the Dow Jones Industrial Average (DJIA) has surged past the 48,000-point threshold, closing at an...
Via
MarketMinute
Topics
Artificial Intelligence
Bonds
Economy
Dow Breaches 48,000 Milestone Amidst Government Shutdown Resolution Hopes, S&P 500 and Nasdaq Lag
November 12, 2025
The Dow Jones Industrial Average (DJIA) made history on Wednesday, November 12, 2025, surging past the 48,000-point mark for the first time ever, gaining nearly 380 points. This significant rally was...
Via
MarketMinute
Topics
Artificial Intelligence
Bonds
Economy
Dow Jones Industrial Average Soars to Record High: A Nuanced Signal for the Economy
November 11, 2025
NEW YORK, NY – November 11, 2025 – The Dow Jones Industrial Average (DJIA) has reached an unprecedented milestone today, soaring to a new all-time high of 47,927.96, a robust gain of 559.33 points...
Via
MarketMinute
Topics
Artificial Intelligence
Bonds
Economy
Dow Jones Industrial Average Soars to New All-Time High Amidst Shifting Market Dynamics
November 11, 2025
New York, NY – November 11, 2025 – The Dow Jones Industrial Average (DJIA) has today surged to an unprecedented all-time high, pushing past significant milestones and reinforcing a complex, yet largely...
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Stocks
Why Amgen Stock Was a Nearly 5% Winner Today
↗
November 11, 2025
The company continued to bask in the glow of a very solid third quarter.
Via
The Motley Fool
Elevance Health, Labcorp, Privia Health, Fortrea, and Amgen Shares Are Soaring, What You Need To Know
November 11, 2025
A number of stocks jumped in the afternoon session after the market experienced a sharp sector rotation, as investors fled growth-oriented technology stocks and piled into value-oriented names amid...
Via
StockStory
Topics
Artificial Intelligence
Stocks
Three Healthcare Buys That Wall Street Loves
↗
November 11, 2025
These three healthcare stocks are outperforming most of the sector.
Via
The Motley Fool
The Top 5 Analyst Questions From Amgen’s Q3 Earnings Call
November 11, 2025
Amgen’s third quarter results were well received by the market, reflecting robust volume-driven growth across its diversified portfolio. Management credited rising demand for key medicines—including...
Via
StockStory
Topics
Earnings
Q3 Rundown: Moderna (NASDAQ:MRNA) Vs Other Therapeutics Stocks
November 10, 2025
Earnings results often indicate what direction a company will take in the months ahead. With Q3 behind us, let’s have a look at Moderna (NASDAQ:MRNA) and its peers.
Via
StockStory
Topics
Artificial Intelligence
2 Cash-Producing Stocks to Research Further and 1 We Find Risky
November 09, 2025
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.
Via
StockStory
Topics
Credit Cards
Merck Takes On Amgen, Regeneron, Lowering Stubbornly High Cholesterol By 60%
↗
November 08, 2025
Merck said Saturday its new pill — a possible rival to Regeneron and Amgen — lowered high cholesterol by almost 60%.
Via
Investor's Business Daily
< Previous
1
2
3
4
5
6
7
8
9
...
61
62
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today